A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancerRichard M. Lush, Anthony W. Tolcher, Michele Trucksis et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 2
To assess the effect of ridaforolimus on the QTc interval in patients with advanced cancer.Danielle Sullivan, A. W. Tolcher, Amita Patnaik et al.|Journal of Clinical Oncology|2011Cited by 0